Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from Nanosonics Limited ( (AU:NAN) ).
Nanosonics Limited held its 2025 Annual General Meeting where all proposed resolutions were successfully carried. The meeting also marked the departure of Dr. Lisa McIntyre from the Board, as previously announced. This outcome reflects strong shareholder support and continuity in the company’s strategic direction, potentially reinforcing its market position and stakeholder confidence.
The most recent analyst rating on (AU:NAN) stock is a Buy with a A$5.00 price target. To see the full list of analyst forecasts on Nanosonics Limited stock, see the AU:NAN Stock Forecast page.
More about Nanosonics Limited
Nanosonics Limited is a global leader in the infection prevention industry, providing advanced solutions primarily focused on reducing the risk of infection in healthcare environments.
Average Trading Volume: 737,564
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$1.37B
Learn more about NAN stock on TipRanks’ Stock Analysis page.